Form 4 for RNXT RenovoRx, Inc.
Accepted 2025-04-09 00:00:00 ET · period of report 2025-04-08 · accession 0001641172-25-003364 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-09 | 2025-04-08 | RNXT | Agah Ramtin | Chief Medical Off, Dir | P - Purchase | $0.84 | +26.0K | 1.05M | +3% | +$21.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-08 | P | A | 26,000 | $0.84 | 1,048,460 | D | — | — | (F1) Reflects open market purchases of the Issuer's securities. (F2) The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.825 to $0.8499, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. (F3) Includes 975,000 shares, which are held of record by the reporting person currently and were held of record by the Mars16 Nevada Non-Grantor Trust Dtd 01/19/2016 and reported as indirectly held by the reporting person previously. |